Commercialization: Page 6
-
A potential COVID-19 EUA could turn this small biotech into a household name
Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.
By Meagan Parrish • May 19, 2022 -
It's time to acknowledge access as a prescribing barrier
A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs.
By Karissa Waddick • May 11, 2022 -
Q&A // Biotech Spotlight
Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia
With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.
By Taren Grom • May 9, 2022 -
Sponsored by EVERSANA
Right-sizing the channel strategy for maximum impact
Failure to right-size your distribution model imposes financial penalties and wasted expenditures.
May 9, 2022 -
Pharma's solution to the digital advertising dilemma? Storytelling
Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.
By Karissa Waddick • May 5, 2022 -
From the fringes to the forefront — the mRNA era has taken hold of pharma
A look at what’s next for the industry’s buzziest technology.
By Kim Ribbink • April 22, 2022 -
Profile
For Global Blood Therapeutics, the connection to sickle cell disease runs deep
An underserved patient population is a guiding light for the company, which recently scored a new approval.
By Robin Robinson • April 19, 2022 -
Q&A
How pharma can up its social media game
Health Union’s VP of community development, Sara Hayes, discusses how pharma marketers can better reach online patient communities.
By Karissa Waddick • April 18, 2022 -
How Congress could play a role in personalized medicine
PGx — a tool to help determine proper dosing — may be poised to achieve broader use in healthcare and pharma.
By Kelly Bilodeau • April 11, 2022 -
Optinose CEO senses big opportunities for the company's nasal delivery device
Peter Miller explains how a repackaged sinus drug has won late-stage clinical success.
By Jared Whitlock • April 11, 2022 -
Q&A
Time-saving tech lights Alcon's path into digital innovation
Kevin Yapp, global head or omni-channel transformation at the Swiss eye health company shares why the customer should be a North Star when developing digital tools.
By Kim Ribbink • April 4, 2022 -
Podcast
Woman of the Week: Daré Bioscience's Sabrina Martucci Johnson
The CEO is setting a path to transform women’s health at an opportune time.
By Taren Grom • March 30, 2022 -
Profile
From media to menopause: Creating new spaces in women's telehealth
Why the former editor-in-chief of Marie Claire abandoned her magazine career to create a menopause-focused women's health startup.
By Alexandra Pecci • March 29, 2022 -
How a rock 'n' roll guru is putting a new spin on health education for patients
A former agent for The Rolling Stones has launched a healthcare streaming platform with a cast of entertainment heavyweights — and he wants pharma to be a headline act.
By Meagan Parrish • March 28, 2022 -
Q&A
Why Astellas is adopting a 'focus area approach' to partnerships
Chief Strategy Officer, Naoki Okamura, explains why new trends and innovations require a different approach to alliances.
By Kim Ribbink • March 22, 2022 -
Virpax's CEO on leveraging new formulations to move drugs toward approval
Anthony Mack shares his lessons from getting unconventional pharma products across the finish line.
By Meagan Parrish • March 18, 2022 -
Podcast
Woman of the Week: Ceek Women's Health CEO Fahti Khosrowshahi
Fahti Khosrowshahi, CEO and founder, Ceek Women’s Health, is designing award-winning products to change the face of women's health.
By Taren Grom • March 16, 2022 -
Q&A // Biotech Spotlight
Liquid biopsy is a multibillion-dollar market, and InterVenn is looking to take advantage
The company’s CEO explains how its liquid biopsy tests target a unique, untapped layer of biology.
By Taren Grom • March 14, 2022 -
Profile
From angel to operator: The unlikely journey of Endevica Bio's CEO
Russell Potterfield is honing his new found passion for the space to guide Endevica into the clinic.
By Jared Whitlock • March 9, 2022 -
Podcast
Woman of the Week: Sumitovant's Chief Business Development and Commercial Officer Adele Gulfo
Adele Gulfo, chief business development and commercial officer at Sumitovant Biopharma, is leaning into her decades of experience to bring a future-focused approach to drug development.
By Taren Grom • Feb. 23, 2022 -
Eisai's mission to shake off Aduhelm's shadow and bring another AD drug to market
The company's senior VP of clinical research on how they're building off the science of Aduhelm to develop better Alzheimer's treatments.
By Kelly Bilodeau • Feb. 23, 2022 -
Podcast
Woman of the Week: Organon's Chief Commercial Officer Susanne Fiedler
Susi Fiedler, chief commercial officer, was instrumental in the spinout of Organon as a standalone company focused on a broad range of women’s health issues.
By Taren Grom • Feb. 16, 2022 -
Profile
How Veru is developing blockbuster drugs while avoiding biotech's 'valley of death'
Why sexual health and telemedicine are key to the company's goals in oncology.
By Meagan Parrish • Feb. 16, 2022 -
Opinion
Industry executives on the milestone moments shaping pharma's future
Scientific, technological, and communication changes that are making a permanent impact on the industry.
By Taren Grom • Feb. 9, 2022 -
Podcast
Woman of the Week: Syneos Health's president of commercial solutions, Michelle Keefe
How Michelle Keefe, president, commercial solutions at Syneos Health, steered her team into a rapid pivot during the pandemic.
By Taren Grom • Feb. 2, 2022